Arylamine N-acetyltransferase 1 gene regulation by androgens requires a conserved heat shock element for heat shock factor-1
Open Access
- 22 February 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 31 (5) , 820-826
- https://doi.org/10.1093/carcin/bgq042
Abstract
Human arylamine N -acetyltransferase 1 (NAT1) is a widely distributed protein that has been implicated in a number of different cancers including breast and prostate. Previously, NAT1 gene expression was shown to be androgen dependent, although the effect of androgens was not due to direct activation of the NAT1 promoter. Here, we show that heat shock factor (HSF)1 is induced by androgen in androgen receptor-positive prostate 22Rv1 cells. It also binds to a heat shock element (HSE) in the NAT1 promoter located 776 bp upstream of the transcriptional start site. Mutation of the HSE inhibited androgen responsiveness and prevented direct upregulation of the NAT1 promoter by HSF1. Although HSF2 also bound to the HSE, it did not increase promoter activity. HSF1 induced endogenous NAT1 activity in this cell line in the absence of androgen. This could be attenuated by pretreating cells with HSF1-directed small interfering RNA but not by a scrambled sequence. Our results show that HSF1 is an important transcription factor for induction of NAT1 in human cells and is required for androgen activation of the NAT1 promoter.Keywords
This publication has 48 references indexed in Scilit:
- Structures of Human Arylamine N-AcetyltransferasesCurrent Drug Metabolism, 2008
- Polymorphisms of Human N-Acetyltransferases and Cancer RiskCurrent Drug Metabolism, 2008
- Arylamine N‐acetyltransferase 1 expression in breast cancer cell lines: A potential marker in estrogen receptor‐positive tumorsGenes, Chromosomes and Cancer, 2007
- Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1Pharmacogenetics and Genomics, 2006
- Genomic organization of human arylamine N-acetyltransferase Type I reveals alternative promoters that generate different 5′-UTR splice variants with altered translational activitiesBiochemical Journal, 2005
- Proteasomal Degradation of N-Acetyltransferase 1 Is Prevented by Acetylation of the Active Site CysteineJournal of Biological Chemistry, 2004
- Pharmacogenetics of the arylamine N-acetyltransferasesThe Pharmacogenomics Journal, 2002
- Structure of arylamine N-acetyltransferase reveals a catalytic triadNature Structural & Molecular Biology, 2000
- Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferasesCarcinogenesis: Integrative Cancer Research, 1993
- N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cellsBiochemical and Biophysical Research Communications, 1992